Found: 11
Select item for more details and to access through your institution.
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 159, doi. 10.1111/bjh.15742
- By:
- Publication type:
- Article
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 601, doi. 10.1111/bjh.15585
- By:
- Publication type:
- Article
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 788, doi. 10.1111/bjh.13773
- By:
- Publication type:
- Article
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 2, p. 219, doi. 10.1111/bjh.13296
- By:
- Publication type:
- Article
The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diagnosis and Management of Multiple Myeloma: A Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 308, doi. 10.1002/ajh.24265
- By:
- Publication type:
- Article
False‐negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosis.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 4, p. 284, doi. 10.1002/ajh.20543
- By:
- Publication type:
- Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
- By:
- Publication type:
- Article